Amerisource Health Services Hydrochlorothiazide Capsules Recall

Why it was recalled

Presence of Particulate Matter

Product description

HYDROCHLOROTHIAZIDE CAPSULES, USP, 12.5 mg, 10 cap/blister, 100-count carton, Rx only, Packaged and Distributed by American Health Packaging Columbus, Ohio 43217, NDC 68084-0398-01

Lot numbers, UPCs & expiration codes

Lot # 151379 and Lot #151380; Exp 12/16

Where it was sold

Nationwide

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-0565-2016
Classification: Class II
Status: Terminated
Recall initiated: Oct 29, 2015
FDA report date: Jan 20, 2016
Quantity: 2,784 cartons (278,400 capsules)
Recall type: Voluntary: Firm initiated
Recalling firm: Amerisource Health Services

Original FDA data

Every field from FDA enforcement report D-0565-2016, exactly as published.

Show all FDA fields

City: Columbus
State: OH
Status: Terminated
Country: United States
Event ID: 72865
Address: 2550 John Glenn Ave
Address (line 2): Suite A
Code information: Lot # 151379 and Lot #151380; Exp 12/16
Postal code: 43217-1188
Report date: Jan 20, 2016
Product type: Drugs
Recall number: D-0565-2016
Classification: Class II
Recalling firm: Amerisource Health Services
Product quantity: 2,784 cartons (278,400 capsules)
Termination date: Jan 11, 2017
Reason for recall: Presence of Particulate Matter
Voluntary / mandated: Voluntary: Firm initiated
Product description: HYDROCHLOROTHIAZIDE CAPSULES, USP, 12.5 mg, 10 cap/blister, 100-count carton, Rx only, Packaged and Distributed by American Health Packaging Columbus, Ohio 43217, NDC 68084-0398-01
Distribution pattern: Nationwide
Recall initiation date: Oct 29, 2015
Initial firm notification: Letter
Center classification date: Jan 8, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0565-2016, published Jan 20, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.